Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACON Diabetes Care is the diabetes-management and related diagnostics business operating under ACON Laboratories, focused on blood glucose monitoring systems and adjacent point-of-care diabetes tests. The business markets the On Call family of products, including blood glucose meters and strips, HbA1c testing systems, dual-analyte glucose/uric acid or glucose/ketone systems, and professional-use diabetes care solutions. Its products are sold internationally and positioned around affordable, reliable diabetes monitoring for home and professional settings. The organization appears to operate as a branded division rather than a standalone independently traded biopharma company, with manufacturing and commercial operations linked to ACON Laboratories and ACON Biotech in China. Overall, it is a commercial-stage healthcare diagnostics/device business rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACON Diabetes Care.